← Browse by Condition
Medical Condition

cardiac magnetic resonance imaging

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for cardiac magnetic resonance imaging sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cardiac magnetic resonance imaging Clinical Trials

How many clinical trials are currently recruiting for cardiac magnetic resonance imaging?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for cardiac magnetic resonance imaging, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cardiac magnetic resonance imaging?
cardiac magnetic resonance imaging research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cardiac magnetic resonance imaging clinical trial?
Eligibility criteria for cardiac magnetic resonance imaging trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
The Affiliated Hospital of Qingdao University 1 trial
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1 trial
Istanbul University - Cerrahpasa 1 trial

Recruiting Clinical Trials

NCT07130409
Recruiting
Multimodal Imaging Assessment After Revascularization in Patients With Acute Myocardial Infarction
Enrollment
20 pts
Location
China
Sponsor
The Affiliated Hospital of Qin...
View Trial →
NCT06813443
Recruiting
Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Enrollment
700 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT07563660
Recruiting
FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))
Enrollment
15 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul University - Cerrahpa...
View Trial →

Related Conditions

acute myocardial infarction ami (1) pet mr (1) cardiomyopathies (1) amyloidosis cardiac (1) fabry disease (1) arrhythmogenic cardiomyopathy (1) hypertrophic cardiomyopathy hcm (1) laminopathies (1) dystrophia myotonica (1) mitochondrial cardiomyopathy (1) dilated cardiomyopathy (1) sudden cardiac death (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology